Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
ResMed Inc. logo
RMD.AX
ResMed Inc.
06:10:32
30.03 A$
0.0000 (%0.00)
Previous Close: 30.31
Day Low₺29.91
Day High₺30.18
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

RMD.AX: ResMed Inc. Financials

ResMed Inc. Income Statement

Total revenue
Net income
Gross margin TTM
60.25%
Operating margin TTM
33.96%
Net profit margin TTM
26.94%
Return on investment TTM
23.65%
Period end30/06/202630/06/202530/06/202430/06/2023
Total revenue5,777,566,0005,146,327,0004,685,297,0004,222,993,000
Operating income1,962,099,0001,685,363,0001,319,893,0001,131,871,000
Net income1,556,737,0001,400,723,0001,020,951,000897,556,000

All line items

Line item30/06/202630/06/202530/06/202430/06/2023
Total revenue5,777,566,0005,146,327,0004,685,297,0004,222,993,000
Cost of revenue2,296,507,0002,091,357,0002,029,994,0001,867,331,000
Gross profit3,481,059,0003,054,970,0002,655,303,0002,355,662,000
Research and development expenses386,590,000331,284,000307,525,000287,642,000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses1,132,369,000991,019,000917,136,000874,003,000
Other expenses047,304,000110,749,000-5,712,000
Operating expenses1,518,960,0001,369,607,0001,335,410,0001,203,665,000
Cost and expenses3,815,467,0003,460,964,0003,365,404,0003,070,996,000
Net interest income51,010,0004,114,000-45,708,000-47,379,000
Interest income51,010,0004,114,00000
Interest expense019,469,42845,708,00047,379,000
Depreciation and amortization249,512,000235,811,000216,209,000196,522,000
EBITDA2,211,612,0001,923,205,0001,533,543,0001,358,801,000
EBIT1,962,099,0001,687,394,0001,310,506,0001,162,279,000
Non-operating income (excl. interest)0-2,031,0009,387,000-30,408,000
Operating income1,962,099,0001,685,363,0001,319,893,0001,131,871,000
Total other income/expenses (net)-542,000-7,797,000-55,095,000-30,207,000
Income before tax1,961,558,0001,677,566,0001,264,798,0001,101,664,000
Income tax expense404,820,000276,843,000243,847,000204,108,000
Net income from continuing operations1,556,737,0001,400,723,0001,020,951,000897,556,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income1,556,737,0001,400,723,0001,020,951,000897,556,000
Net income deductions0000
Bottom line net income1,556,737,0001,400,723,0001,020,951,000897,556,000
EPS10.96290.70660.6038
Diluted EPS10.95880.7040.6009
Weighted average shares outstanding1,455,230,0001,467,160,0001,470,210,0001,467,650,000
Weighted average diluted shares outstanding1,460,540,0001,473,400,0001,475,500,0001,474,550,000

ResMed Inc. Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
399,242,046%
Total debt / assets MRQ
—
Period end30/06/202630/06/202530/06/202430/06/2023
Total assets8,962,067,6018,174,391,0006,872,394,0006,751,708,000
Total liabilities2,379,526,1802,206,532,0002,008,351,0002,621,805,000
Total equity6,582,541,4205,967,859,0004,864,043,0004,129,903,000

All line items

Line item30/06/202630/06/202530/06/202430/06/2023
Cash and cash equivalents1,468,597,7981,209,450,000238,361,000227,891,000
Short-term investments0000
Cash and short-term investments1,468,597,7981,209,450,000238,361,000227,891,000
Net receivables1,035,784,294990,667,000837,275,000704,909,000
Accounts receivable1,035,784,294939,492,000837,275,000704,909,000
Other receivables051,175,00000
Inventory945,395,450927,711,000822,250,000998,012,000
Prepaid expenses0213,279,000279,821,000257,093,000
Other current assets873,088,777164,498,000180,012,000179,925,000
Total current assets4,322,866,3193,505,605,0002,357,719,0002,367,830,000
Property, plant and equipment (net)734,677,734718,287,000699,146,000665,811,000
Goodwill2,909,575,0003,046,680,0002,842,055,0002,770,299,000
Intangible assets452,737,000464,861,000485,904,000552,341,000
Goodwill and intangible assets3,360,856,0653,511,541,0003,327,959,0003,322,640,000
Long-term investments157,380,000129,752,057169,766,000-132,974,000
Tax assets0253,119,000203,569,000132,974,000
Other non-current assets386,287,482185,839,000114,235,000395,427,000
Total non-current assets4,639,201,2814,668,786,0004,514,675,0004,383,878,000
Other assets0000
Total assets8,962,067,6018,174,391,0006,872,394,0006,751,708,000
Total payables406,854,748446,015,000237,728,000150,756,000
Accounts payable308,789,231278,157,000237,728,000150,756,000
Other payables98,065,517167,858,00000
Accrued expenses0363,974,000223,862,000220,785,000
Short-term debt259,950,0009,900,00035,178,00031,821,000
Capital lease obligations (current)29,141,00030,506,00025,278,00021,919,000
Tax payables0167,858,000107,517,00072,224,000
Deferred revenue162,840,456166,030,000152,554,000138,072,000
Other current liabilities535,719,6902,695,000236,055,000195,180,000
Total current liabilities1,394,505,8941,019,120,000910,655,000758,533,000
Long-term debt399,242,046658,392,000697,313,0001,431,234,000
Capital lease obligations (non-current)137,353,497153,015,000141,444,000116,853,000
Deferred revenue (non-current)170,876,975156,803,000137,343,000119,186,000
Deferred tax liabilities (non-current)64,612,00977,682,00079,339,00090,650,000
Other non-current liabilities212,935,756141,520,00042,257,000105,349,000
Total non-current liabilities985,020,2851,187,412,0001,097,696,0001,863,272,000
Other liabilities0000
Capital lease obligations166,494,497183,521,000166,722,000138,772,000
Total liabilities2,379,526,1802,206,532,0002,008,351,0002,621,805,000
Treasury stock-2,777,387,826-2,073,292,000-1,773,267,000-1,623,256,000
Preferred stock0000
Common stock763,668761,000588,000588,000
Retained earnings7,251,979,4176,081,490,0004,991,647,0004,253,016,000
Additional paid-in capital2,189,665,4292,033,599,0001,896,604,0001,772,083,000
Accumulated other comprehensive income/loss-82,479,269-74,699,000-251,529,000-272,528,000
Other stockholders' equity0000
Total stockholders' equity6,582,541,4205,967,859,0004,864,043,0004,129,903,000
Total equity6,582,541,4205,967,859,0004,864,043,0004,129,903,000
Minority interest0000
Total liabilities and total equity8,962,067,6018,174,391,0006,872,394,0006,751,708,000
Total investments157,380,000149,710,860169,766,000-132,974,000
Total debt825,561,363851,813,000899,213,0001,579,908,000
Net debt-643,036,435-357,637,000660,852,0001,352,017,000

ResMed Inc. Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end30/06/202630/06/202530/06/202430/06/2023
Cash from operations1,845,476,6611,751,588,0001,401,260,000693,299,000
Cash from investing-557,169,051-200,045,000-269,784,000-1,159,845,000
Cash from financing-1,029,138,704-606,253,000-1,119,287,000422,874,000
Net change in cash190,587,225971,089,00010,470,000-45,819,000

All line items

Line item30/06/202630/06/202530/06/202430/06/2023
Net income1,556,737,4761,400,723,0001,020,951,000897,556,000
Depreciation and amortization249,512,449235,811,000216,209,000197,562,000
Deferred income tax000216,000
Stock-based compensation091,661,00080,184,00071,142,000
Change in working capital-75,873,03216,738,00044,784,000-462,127,000
Accounts receivable-98,902,797-76,684,000-134,278,000-106,511,000
Inventory-10,137,796-80,165,000172,203,000-248,833,000
Accounts payable176,507,0230031,342,000
Other working capital-143,339,461173,587,000-127,419,000-138,125,000
Other non-cash items115,099,7686,655,00039,132,000-11,050,000
Net cash from operating activities1,845,476,6611,751,588,0001,401,260,000693,299,000
Investments in property, plant and equipment-181,062,900-89,865,000-99,460,000-134,000,000
Acquisitions (net)-358,424,278-139,248,000-133,464,000-1,012,749,000
Purchases of investments-29,162,518-6,416,000-22,464,000-32,229,000
Sales/maturities of investments2,812,42146,261,0001,000,00019,133,000
Other investing activities8,668,224-10,777,000-15,396,00015,196,000
Net cash from investing activities-557,169,051-200,045,000-269,784,000-1,159,845,000
Net debt issuance-10,219,553-40,000,000-730,000,000665,000,000
Long-term net debt issuance-10,219,553-40,000,000-730,000,000665,000,000
Short-term net debt issuance0000
Net stock issuance-639,267,836-225,586,000-96,917,00049,142,000
Net common stock issuance-639,267,836-225,586,000-96,917,00049,142,000
Common stock issuance76,138,74174,439,00053,094,00049,142,000
Common stock repurchased-715,406,578-300,025,000-150,011,0000
Net preferred stock issuance0000
Net dividends paid-357,338,961-310,880,000-282,320,000-258,276,000
Common dividends paid-357,338,961-310,880,000-282,320,000-258,276,000
Preferred dividends paid0000
Other financing activities-22,312,352-29,787,000-10,050,000-32,992,000
Net cash from financing activities-1,029,138,704-606,253,000-1,119,287,000422,874,000
Effect of FX changes on cash-68,581,68025,799,000-1,719,000-2,147,000
Net change in cash190,587,225971,089,00010,470,000-45,819,000
Cash at end of period1,468,597,7981,209,450,000238,361,000227,891,000
Cash at beginning of period1,278,010,572238,361,000227,891,000273,710,000
Operating cash flow1,845,476,6611,751,588,0001,401,260,000693,299,000
Capital expenditure-159,716,294-100,642,000-114,856,000-134,000,000
Free cash flow1,685,760,3671,650,946,0001,286,404,000559,299,000
Income taxes paid0214,013,000278,400,000216,866,000
Interest paid028,415,00045,708,00047,379,000